Drug-eluting stents: the panacea for restenosis?
Lim
M C L
MC
D015906:Angioplasty, Balloon, Coronary; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D020099:Coated Materials, Biocompatible; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000209:etiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D016503:Drug Delivery Systems; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D017239:Paclitaxel / Q000008:administration & dosage*; D011108:Polymers; D016032:Randomized Controlled Trials as Topic; D020123:Sirolimus / Q000008:administration & dosage*; D013193:Stainless Steel; D015607:Stents / Q000009:adverse effects / Q000191:economics
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D020099:Coated Materials, Biocompatible; D007166:Immunosuppressive Agents; D011108:Polymers; D013193:Stainless Steel; D017239:Paclitaxel; D020123:Sirolimus